Interleukin-2: Difference between revisions
(CSV import) |
(CSV import) |
||
| Line 1: | Line 1: | ||
{{Definitions | {{Definitions | ||
|Term=Interleukin-2 | |Term=Interleukin-2 | ||
|Short definition=Interleukin- | |Short definition=Interleukin-2 (inter-LOO-kin. | ||
|Type=Cancer terms | |Type=Cancer terms | ||
|Specialty=Oncology | |Specialty=Oncology | ||
Latest revision as of 00:10, 12 January 2023
| Interleukin-2 | |
|---|---|
| Term | Interleukin-2 |
| Short definition | Interleukin-2 (inter-LOO-kin. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Interleukin-2 - (pronounced) (inter-LOO-kin. . . ) One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. Interleukin-2 is made by a type of T lymphocyte. It increases the growth and activity of other T lymphocytes and B lymphocytes and affects the development of the immune system. Aldesleukin (interleukin-2 produced in the laboratory) is used as a biological reaction modifier to strengthen the immune system in cancer therapy. Interleukin-2 is a type of cytokine. Also called IL-2
External links
- Medical encyclopedia article on Interleukin-2
- Wikipedia's article - Interleukin-2
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski